AtriCure provides innovative technologies for the treatment of Afib and related conditions. The Isolator® Synergy™ Ablation System is FDA approved for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices in the world.

Biosense Webster, Inc. is the global market leader in the science and technology behind the diagnosis and treatment of cardiac arrhythmias. Part of the Johnson & Johnson MedTech, the specialized medical technology company is headquartered in Irvine, California, and works across the world to advance tools and solutions that help electrophysiologists identify, treat, and deliver care. Learn more at www.biosensewebster.com and connect on LinkedIn and X, formerly Twitter.

About Johnson & Johnson 

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers 
us to build a world where complex diseases are prevented, treated, and cured, where treatments are
smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine 
and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

Bold thinking. Bolder actions. We are Medtronic.
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.
In everything we do, we are engineering the extraordinary.

Haemonetics Vascular Closure develops innovative medical technology. VASCADE MVP® Venous Vascular Closure System (6-12F ID; maximum 15F OD) is simple and easy to use with 0% major complications* in 1,223 patients in 5 EP studies,1-5 and is approved for same day discharge and multi-stick, multi-limb use following cardiac ablation procedures. 1-5, * For more information on this clinical data, please visit: hospital.Haemonetics.com/vascular-closure/vascade-mvp

Boston Scientific transforms lives through innovative solutions that improve the health of patients around the world.  As a global medical technology leader for over 40 years, we advance science for life by providing a broad range of performance solutions that address unmet patient needs and reduce health care costs.  

Abbott Vascular offers the pioneering Perclose Closure Device, designed for closure of arterial and venous vessels. Specifically tailored for multi-access ablation cases, this device provides precision and reliability in achieving secure vessel closure, ensuring optimal outcomes, 1 hour to ambulation, and enhancing procedural efficiency in diverse vascular interventions.

AuST Group is a medical device development and manufacturing firm with deep expertise relating to EP catheters, including PFA, deflectable sheaths, and lead delivery systems.
We are the gold standard in taking devices from concept to product because of a process that focuses on rapid iteration and ample clinician feedback.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital
solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make
hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing
personalized, connected, and compassionate care, while simplifying the patient’s journey across the
care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical
Diagnostics businesses help improve patient care from prevention and screening, to diagnosis,
treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to
create a world where healthcare has no limits.
 
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our
website gehealthcare.com for more information.

Nuubo is the only non-adhesive, wearable ECG monitor, tailored for patient comfort and ease of use. It's an ideal solution for a wide range of patients, particularly beneficial for those with sensitive skin or various chronic conditions. Nuubo's innovative design significantly reduces skin irritation, streamlining the monitoring process for everyone.

Nuubo embodies a patient-centric approach to continuous cardiac monitoring. It plays a pivotal role in the early detection of potential cardiac issues, enabling prompt adjustments in treatment plans and fostering a proactive stance in cardiac healthcare. This comfortable, non-intrusive device has proven to achieve high patient compliance rates, an essential factor in effective care management across various healthcare settings. 

Nuubo's skin-friendly cardiac monitoring solution caters to a broad patient demographic, offering a gentler, adhesive-free alternative without compromising the quality of cardiac insights. Equipped with a 2-lead ECG and four integrated sensors, Nuubo delivers precise, comprehensive data, making it ideal for monitoring sporadic cardiac symptoms, arrhythmias, and AFIB, as well as assessing the effectiveness of treatments for abnormal heart rhythms.  

Nuubo's innovative non-adhesive design ensures safe and effective cardiac monitoring for all patient groups, including those who are sensitive to traditional adhesive-based systems. This inclusivity allows a wider range of patients to benefit from advanced cardiac monitoring, thereby elevating the standard of care they receive.  Nuubo is redefining cardiac health monitoring with a focus on accessibility, comfort, and comprehensive care.

Your Cardiac Remote Monitoring Solution. 
Easy to implement. Easy to use. Easy to prioritize. 
Simplify the complex. Transform your workflows. Generate new revenue. Focus on the actionable first with confidence. All from one intelligent dashboard—the only fully interoperable cardiac remote monitoring platform available. PaceMateLIVE™—smarter and simpler for all. www.pacemate.com